Supriya Lifescience IPO GMP Today, Supriya Lifescience IPO Grey Market Premium Updates | Supriya Lifescience IPO Listing Gain, Latest target, Opening gain
Supriya Lifescience IPO date fixed, the initial public offer (IPO) to hit the market on December 16, 2021. Supriya Lifescience IPO to raise ₹700 crores via IPO. The retail quota is 10% with QIB 75% and HNI 15%.
Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anesthetic, vitamin, anti-asthmatic and anti-allergic. The company has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India between Fiscal 2017 and 2021. The company is also one of the largest exporters of Salbutamol Sulphate from India in FY 2021 in terms of volume.
In Fiscal 2021, the company’s products were exported to 86 countries to 1,296 customers including 346 distributors. The company has API business in Europe, Latin America, Asia, and North America. Supriya Lifescience has a modern manufacturing facility in Maharashtra spread across 23,806 sq. mts, having a reactor capacity of 547 KL/ day including 7 clean rooms.
Check out Supriya Lifescience IPO grey market premium, Kostak rates, and subject to sauda rates as of today.
Supriya Lifescience IPO Details:
|Issuer||Supriya Lifescience Limited|
|Issue Type||Book Built Issue IPO|
|Issue Period||Issue Opens: Dec 16, 2021|
|Issue Closes: Dec 20, 2021|
|Price Brand||₹265 to ₹274 Per Share|
|Issue Size||₹700 Crores|
|Face Value||Rs.2 per Equity Share|
|Market Lot||54 Shares|
|Maximum Bid amount for Retail||Rs.192,348|
|QIB||75% of the issue size|
|NIB||15% of the issue size|
|Retail Individual Bidders||10% of the issue size|
|Fresh Issue||₹200 Cr|
|Offer for Sale||₹500 Cr|
|Listing at||NSE & BSE|
|Apply With||Upstox Free DEMAT Account|
|Grey Market Price||Supriya Lifescience IPO GMP|
|UPCOMING IPO 2021||UPCOMING DIVIDEND|
|UPCOMING BUYBACK||UPCOMING NCD 2021|
|Best Stocks to Buy||Latest IPO Grey Market Premium|
|CMS Infosystems IPO GMP||Metro Brands IPO GMP|
|MapmyIndia IPO GMP||HP Adhesives IPO GMP|
|Medplus Health IPO GMP||Data Patterns IPO GMP|
Supriya Lifescience IPO GMP Rates day by day
Supriya Lifescience IPO Grey market premium as of today
|Date||GMP (in INR)||Kostak (in INR)||Subject to Sauda|
|29 DEC 2021|
|28 DEC 2021|
|27 DEC 2021||₹140||₹200||₹6000|
|26 DEC 2021||₹100||₹200||₹6000|
|25 DEC 2021||₹120||₹200||₹6000|
|24 DEC 2021||₹110||₹200||₹6000|
|25 DEC 2021||₹120||₹200||₹6000|
|24 DEC 2021||₹132||₹200||₹6000|
|23 DEC 2021||₹130||₹200||₹6000|
|22 DEC 2021||₹100||₹200||₹6000|
|21 DEC 2021||₹100||₹200||₹6000|
|20 DEC 2021||₹130||₹200||₹6000|
|19 DEC 2021||₹190|
|18 DEC 2021||₹230||₹6000|
|17 DEC 2021||₹300|
|16 DEC 2021||₹300|
|15 DEC 2021||₹260|
|14 DEC 2021||₹250|
|13 DEC 2021|
|12 DEC 2021|
|11 DEC 2021|
|10 DEC 2021||₹400|
|09 DEC 2021||₹250|
Supriya Lifescience IPO Market Lot:
|Lot Size:||Minimum 54 Shares & Maximum 702 Shares|
Supriya Lifescience IPO Allotment & Listing:
|Basis of Allotment:||Dec 23, 2021|
|Refunds:||Dec 24, 2021|
|Credit to Demat Account:||Dec 27, 2021|
|Listing Date:||Dec 28, 2021|
How to Apply for Supriya Lifescience IPO?
If you’re a new investor Open DEMAT Account for free with Angel Broking and build wealth with the best stock choices. Join 1 million+ family of happy customers.
How to Apply the Supriya Lifescience IPO through Zerodha?
Log in to Console in Zerodha Website or in Application. Go to Portfolio and Click on IPO. You will see the IPO Name “Supriya Lifescience”. Click on Bid Button. Enter your UPI ID, Quantity and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Zerodha.
How to Apply the Supriya Lifescience IPO through Upstox?
Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Supriya Lifescience”. Click on Bid Button. Confirm your application. Now go to your UPI App on Net Banking or BHIM App to Approve – mandate. Open Demat Account with Upstox.
In case you have not been allotted or for any partial allotment of IPO shares, the blocked amount, if any, will be unblocked/released on or before UPI mandate expiry date. Please reach out to your bank in case funds are not unblocked/released post the mandate expiry date.
PARENT COMPANY FOR SHAREHOLDER QUOTA
IPO ALLOTMENT TIPS & TRICKS
Check:- Supriya Lifescience IPO Allotment Status
– IPO Grey Market Premium (IPO GMP) mention is valid for the specific date as mentioned in the header.
– We are not buying and selling IPO forms on IPO Grey Market.
– Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
– Do not subscribe for IPO by just seeing premium Price as it may change anytime before listing. Subscribe only considering Fundamental of the companies.
– This is only coverage of News related to Grey Market . We don’t deal in Grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
IPO GMP rates are provided as sourced from market intelligence. Please note these IPO GMP rates may be different depending on geographies and markets.
We don’t trade into grey market nor do we facilitate buying or selling of IPO forms.
What is Grey Market?
Grey Market is the term used to describe an unregulated over-the-counter market for trading IPO applications and IPO shares before the stock is listed at a stock market. This is a way for dealers to support their customers who may want to exit before listing.
This is also a way to boost the listing price and support the issue before listing happens. There are two kinds of transactions that happen in thee IPO grey market:
- Trade of IPO shares at a grey market premium
- Trade of IPO application at a kostak.
What is Grey Market Premium?
GMP or Grey Market Premium is the premium at which equity shares from the IPO are being traded in the grey market.
This could either be a positive or negative – meaning the trading price in the grey market is either higher or lower than issue price respectively, based on demand and supply for the shares.
Typically, investors who do not want to take the risk of allocation not happening through IPO will buy shares in the gray market and hope to flip the shares on listing to make a good profit.
What is Kostak?
Kostak is the premium at which IPO application is being traded in the grey market. Applications are typically traded after the application window is closed but the allotment has not yet been finished.
It is rare for someone to trade IPO application post-allocation. This is a way for investors to increase their chance of shares being allotted as the allocation process treats each retail application equally. An example (indicative) for kostak is:
Issue Price: Rs 306 Per Equity Share (Maximum Bid price)
Lot Size: 45
Grey Market Premium: Rs 220 to Rs 230
Kostak (Rs 13770): Rs 680 to Rs 720
This means IGL IPO applications of Rs 13500 are being traded in IPO Grey Market at Rs 695 to Rs 720.
Despite the fact that this IPO’s Grey Market Premium is roughly 75% of the issue price, the ‘Kostak’ is just 5% of the application value.
As can be seen the Kostak is at a much lower %age than GMP. This indicates that the grey market expects the issue to be oversubscribed and expects on an average only one lot to be allocated per application.
Kostak rate is the amount an investor gets by selling his/her IPO application in grey market. This is the amount an investor stands to gain, irrespective of allotment status.
Subject to Sauda simply reflects the amount which an investor stands to get by selling his/her application for firm allotment. The key operative word here is firm allotment. In case of no allotment to the applicant, the sauda stands cancelled.
In case of ‘Subject to Sauda’ deal, while selling IPO application in the grey market, buyer and seller agree that deal is only valid if the seller will get the allotment. If the seller doesn’t get any shares in IPO process, the deal gets avoid.